Marie Masson Regnault

6PUBLICATIONS
13CO-AUTHORS
Toxicology (incl. clinical toxicology)Cancer therapy (excl. chemotherapy and radiation therapy)Colloid and surface chemistryApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 31, 2025
French guidelines on systemic treatments for moderate-to-severe psoriasis in adults: Update 2025.

Marie Masson Regnault, Emilie Brenaut, Marie-Emeline Marniquet

|Mar 22, 2025
Real-life effectiveness and safety of baricitinib in adults with alopecia areata: A multicentre study.

A Mourtada, C Douarec, M Wargny

|Apr 30, 2022
Time to Relapse After Discontinuing Systemic Treatment for Psoriasis: A Systematic Review.

Marie Masson Regnault, Jason Shourick, Fatma Jendoubi

|Apr 22, 2020
Comment on 'Cutaneous manifestations in COVID-19: a first perspective' by Recalcati S.

M Hedou, F Carsuzaa, E Chary

|Nov 10, 2019
Spider-like injection site reaction after subcutaneous administration of haematological treatments.

M-A Plume, V Sibaud, A Bobin

|Jun 30, 2017
No detection of Merkel cell polyomavirus in oral lichen planus: Results of a preliminary study in a French cohort of patients.

Marie Masson Regnault, Emmanuelle Vigarios, Fabrice Projetti

Pageof 1